July 26, 2018
Mike Yates, vice president of finance with Cancer Treatment Centers of America® in Tulsa, shares his thoughts on the evolving health care landscape.
Read More
July 26, 2018
Mike Yates, vice president of finance with Cancer Treatment Centers of America® in Tulsa, shares his thoughts on the evolving health care landscape.
Read MoreJuly 24, 2018
Cancer Treatment Centers of America (CTCA) in Tulsa patient Marge Gadd first thought she had allergies. Weeks later when she couldn’t breathe through her nose and then experienced a major nose bleed. That convinced her to see a doctor.
Read MoreJuly 20, 2018
Follicular lymphoma is the second more common subtype of non-Hodgkin lymphoma and the most common indolent non-Hodgkin lymphoma. Despite the fact that follicular lymphoma is not typically curable with conventional treatment, current treatments are...
Read MoreJuly 13, 2018
After a remarkable battle with ovarian cancer, a Sterling, Va. woman and five-year cancer survivor has an important message to spread: Never give up hope.
Read MoreJuly 11, 2018
Loretta Brunetti who is a volunteer at Cancer Treatment Centers of America in Tulsa was awarded a Daily Point of Light for the time and energy she dedicates to the hospital. The high-spirited 77-year-old has made it her life’s passion to giving back...
Read MoreJuly 9, 2018
Watching our loved ones in a medical crisis is hard enough. But when you are an oncology nurse and your loved one passes away from the disease, it can be very difficult to return to work. Mena Evans, RN, BSN, OCN, who recently celebrated her 25th...
Read MoreJune 28, 2018
Cancer Treatment Centers of America® (CTCA), Chicago, has been granted Magnet® redesignation for excellence in nursing by the American Nurses Credentialing Center (ANCC).
Read MoreJune 22, 2018
Medical oncologists are utilizing an FDA-approved treatment called talimogene laherparepvec (T-VEC) therapy to fight melanoma.
Read MoreJune 22, 2018
Ankur Parikh, DO, Medical Director of Precision Medicine at Cancer Treatment Centers of America® (CTCA), recently authored a commentary in STAT discussing the importance of extending promising cancer treatments to older patients.
Read MoreJune 21, 2018
Medical oncologists at Cancer Treatment Centers of America are utilizing the FDA-approved treatment called talimogene laherparepvec (T-VEC) therapy to fight melanoma.
Read MoreCancer Treatment Centers of America® (CTCA) is now City of Hope®, a national, integrated cancer research and treatment system, united to expand patient access to personalized comprehensive cancer care across the United States. Learn what that means for you.